Concepedia

Jonas Ristau

JR

Statistics

Publications

17

Citations

615

H-Index

15

Active since

2014

Affiliations

Heidelberg University(Current)

German Cancer Research Center

University Hospital Heidelberg

National Center for Tumor Diseases

Heidelberger Institut für Radioonkologie

Jonas Ristau is an author at Heidelberg University specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2014–2024

17

Publications

17

<i>EML4‐ALK</i> fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK<sup>+</sup> non‐small cell lung cancer

Petros Christopoulos, Volker Endris, Farastuk Bozorgmehr et al. · International Journal of Cancer · 2018 · 119 citations · Full text

Identification of a highly lethal V3<sup>+</sup>TP53<sup>+</sup> subset in ALK<sup>+</sup> lung adenocarcinoma

Petros Christopoulos, Martina Kirchner, Farastuk Bozorgmehr et al. · International Journal of Cancer · 2018 · 103 citations · Full text

FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies

Katharina Dendl, Rebecca Finck, Frederik L. Giesel et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 58 citations · Full text

Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer

Jonas Ristau, Frederik L. Giesel, Matthias F. Haefner et al. · Molecular Imaging and Biology · 2020 · 43 citations · Full text

Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Recurrent Pancreatic Cancer

Jakob Liermann, Mustafa Syed, Edgar Ben‐Josef et al. · Cancers · 2021 · 41 citations · Full text

, , +16

1–5 of 17